µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º Lljn\5!r<
^b8~X [1J_
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ p+d-7'?I
DR#" 3
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) 28MMH
Q
^m>4<~/
1. ICAM-1 B8@mL-Z-;
y'R}
2. interleukin 12(IL-12) UC!mp?
ai!u+L
3. tumor infiltrating lymphocyte mQ[$U
/3b*dsYsl
4. TCR/CD3 complex 2b"*~O;
) c@gRb~
5. hematopoietin receptor family c./\sN@
;blL\|ch;
6. individual idiotype(IdI) Z\!,f.>g
,.,8-In^
7. integrin h@,ja
(v]%kXy/G
8. colony-stimulatory factor (CSF) 3[m~-8
`+H=3`}X
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ",#.?vT`
@Z5q2Q
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? MB]E[&Q!
'xW=
qboOp
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ (.J/Ql0Y
\/
bd
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ]N>ZOV,>
eg[EFI.h
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ >AJ/!{jD*
bt}8ymcG
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 4I4m4^
I%T+H[,
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ !3b& S
4
6)INr,d
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) o}N@Q-i gq
L
8 P0bNi
3. immunoglobulin superfamily (IgSF) fNNl1Vls
VU3RFl
4. selectin 2BccE
d4y#n=HnnV
5. anti-idiotypic antibody (¦ÁId) *i"9D:
r)<A YX]J
6. major histocompatibility complex(MHC) J= A)]YE
*byUqY3(
7. immunotolerance \Ec<ch[)c
EX)&|2w
8. biological reponse modifier(BRM) ,%pCcM)
r-qe7K@p
9. immune reponse gene (Ir gene) eMGJx "a
pGie!2T E
10. reshaped antibody (or reconstituted antibody) @IG's-
TQR5V\{&%
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 4Kj.o
}Rh\JDiQ
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ D]~K-[V?l
<H-Nft>O
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? yZlT#^$\
oidZWy
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ y
4i3m(S
LL<xygd
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? x?AG*'
h&
~&Z>fgOTJ
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ 'z}
t= ?
66val"^W
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? EL,k z8
3?o4
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ <+QdBp'd;
ZSf &M
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ TFXBN.?9T
7I3_$uF
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? 4 OPY
'#6eUb
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ r;Sk[Y5#
OnTe_JML
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ]\*^G@HA2
oSCaP,P
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: U[wx){[|
kj6:P$tH
̉񧄤 UA<Fxt
--$* q"
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© J&8KIOz14Z
=x<N+vjXY
1. CD8 j
[U#J
Gxw1P@<F:
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) XPd mz !,b
f~VlCdf+
3. immunoglobulin fold(Ig fold) Znb={hh
>jt2vU@t.
4. cadherin (Ca-dependent cell adhesion moleculers) x;~:p;]J2F
/DAR'9@h
5. idiotype-anti-idiotypic antibody immune network theory &jJu=6 U
B
?X@!jB,Pv
6. HLA class II antigen {s8c@-'
v~mVf.j1
7. complementarity-determining region (CDR) *2h%dT:,%
?
Bf>G]zx
8. perforin(or pore-forming protein ,PFP) -Q20af-
_,drOF|e
9. high affinity IL-2 receptor gGrVpOzBj
@f-:C+(Nsg
10. artificial active immunization _ $a3lR
3-/|G-4k7
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Da-Lf2qT9
A|ZT;\
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ` @ QZK0Ox
M`Q$-#E:
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 BA h'H&;V
Ja6 KO2}p
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ ?oYO !
5_(\Cd<#
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ CV0id&Nv
Y
D<3#Dr]
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ a&'9[9E1
]^ R':YE
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨?
y-hTTd"{
I0
mp [6
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ it}h8:^<
GlJ[rD
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ }2]|*?1,
T1C_L?
L
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ M86"J:\u]
.?u<|4jE6
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ {.LJ(|(Mz
d`/8Q9tQ
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© :A8r{`R'N
|"}rdOV)
1. immunoglobulin gene rearrangement /bykIUTKI
+<Gp >c
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) <{W{
Y\_A>
Z#}sK5s
3. flow cytometry(FCM) i"V.$|,
S})f`X9_}
4. carrier effect $6n
J+
J?V$V
>d
5. positive selection of T lymphocytes in thymus !/,oQoG
pEwo}NS*H
6. mouse TH1(Th1) and TH2(Th2) subsets |pHlBzHj
-1dD~S$
7. perforin (pore-forming protein ,PFP) Zv}F?4T~:
H|aFs.S EQ
8. ADCC(antibody-dependent cell-mediated cytotoxicity) - ;gQy[U
LZ)g&A(j?
9. SH-2(src-homology region 2) t0f7dU3e;L
n>)aw4
10. Ab2¦Â (internal image) :? )!yI
i1x4$}
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ,<Cl^ ^a,
N&G'i.w/
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? 3!9JXq%Hl
Ar\fA)UQ`
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? +7%?p"gEY\
fK:4jl-r
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠHx6ODj[-
r??_2>Q
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ >h%>s4W
q+[ )i6!?
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠg5#LoGc
u)h
{"pP
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) _v#puFy
@"s<0T^H
ÃâÒßѧרҵ£º 7Wef[N\x
~ ?nn(Q-
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ =xkaF)AW&v
&M5v EPR
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 9Avj\G
]?_~QE`
´«È¾²¡Ñ§×¨Òµ£º >A{e
,&